RCC
Red Cedar Capital Portfolio holdings
AUM
$158M
This Quarter Return
-23.3%
1 Year Return
-6.56%
3 Year Return
+43.18%
5 Year Return
+80.81%
10 Year Return
–
AUM
$99.8M
AUM Growth
+$99.8M
(-24%)
Cap. Flow
+$1.47M
Cap. Flow
% of AUM
1.47%
Top 10 Holdings %
Top 10 Hldgs %
55.25%
Holding
149
New
3
Increased
25
Reduced
14
Closed
4
Top Buys
| 1 |
HCA Healthcare
HCA
|
$1.39M |
| 2 |
Boston Omaha
BOC
|
$932K |
| 3 |
TJX Companies
TJX
|
$858K |
| 4 |
US Bancorp
USB
|
$662K |
| 5 |
Teva Pharmaceuticals
TEVA
|
$612K |
Top Sells
| 1 |
LSXMA
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
|
$2.12M |
| 2 |
MFA
MFA Financial
MFA
|
$1.28M |
| 3 |
Openlane
KAR
|
$673K |
| 4 |
Diageo
DEO
|
$431K |
| 5 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
$427K |
Sector Composition
| 1 | Industrials | 20.01% |
| 2 | Financials | 17.83% |
| 3 | Consumer Discretionary | 16.47% |
| 4 | Consumer Staples | 14.62% |
| 5 | Healthcare | 13.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Markel Group
MKL
$24.8B
| $1.11M | 1.11% |
1,197
| – | – |
|
27
Apple
AAPL
$3.45T
| $1.04M | 1.04% |
4,090
| – | – |
|
|
28
Teva Pharmaceuticals
TEVA
$21.1B
| $1.03M | 1.04% |
115,173
+68,176
| +145% | +$612K |
|
29
UnitedHealth
UNH
$281B
| $1.01M | 1.02% |
4,062
| – | – |
|
30
Enovis
ENOV
$1.77B
| $886K | 0.89% |
44,767
| – | – |
|
|
31
Openlane
KAR
$3.07B
| $699K | 0.7% |
58,272
-56,063
| -49% | -$673K |
|
32
CarMax
KMX
$9.21B
| $659K | 0.66% |
12,249
| – | – |
|
33
CVS Health
CVS
$92.8B
| $625K | 0.63% |
10,530
| – | – |
|
34
3M
MMM
$82.8B
| $511K | 0.51% |
3,743
| – | – |
|
35
Bank of America
BAC
$376B
| $488K | 0.49% |
22,985
| – | – |
|
36
Home Depot
HD
$405B
| $477K | 0.48% |
2,553
| – | – |
|
37
Brookfield
BN
$98.3B
| $472K | 0.47% |
10,673
-87
| -0.8% | -$3.85K |
|
|
IAA
38
DELISTED
IAA, Inc. Common Stock
IAA
| $466K | 0.47% |
15,563
+700
| +5% | +$21K |
|
39
Amgen
AMGN
$155B
| $462K | 0.46% |
2,280
| – | – |
|
40
Allstate
ALL
$53.6B
| $459K | 0.46% |
5,000
| – | – |
|
41
Moody's
MCO
$91.4B
| $438K | 0.44% |
2,070
| – | – |
|
42
American Express
AXP
$231B
| $432K | 0.43% |
5,041
-131
| -3% | -$11.2K |
|
43
Schwab US Large- Cap ETF
SCHX
$59B
| $420K | 0.42% |
6,860
+39
| +0.6% | +$2.39K |
|
44
Brown-Forman Class B
BF.B
$14.2B
| $405K | 0.41% |
7,291
| – | – |
|
45
Baxter International
BAX
$12.7B
| $397K | 0.4% |
4,893
| – | – |
|
46
Amdocs
DOX
$9.41B
| $351K | 0.35% |
6,380
| – | – |
|
47
Johnson & Johnson
JNJ
$427B
| $270K | 0.27% |
2,058
| – | – |
|
48
Advance Auto Parts
AAP
$3.66B
| $267K | 0.27% |
2,862
| – | – |
|
|
RDS.A
49
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $262K | 0.26% |
7,499
-353
| -4% | -$12.3K |
|
50
Novartis
NVS
$245B
| $259K | 0.26% |
3,140
| – | – |
|